These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35967948)

  • 41. Improved local control without elective nodal radiotherapy in patients with unresectable NSCLC treated by 3D-CRT.
    Yang K; Cao F; Wang J; Liu L; Zhang T; Wu G
    Front Med China; 2007 Oct; 1(4):381-5. PubMed ID: 24573930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Li DJ; Li HW; He B; Wang GM; Cai HF; Duan SM; Liu JJ; Zhang YJ; Cui Z; Jiang H
    J BUON; 2016; 21(5):1268-1273. PubMed ID: 27837632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival.
    Watkins JM; Wahlquist AE; Zauls AJ; Shirai K; Garrett-Mayer E; Aguero EG; Silvestri GA; Sherman CA; Sharma AK
    J Med Imaging Radiat Oncol; 2010 Oct; 54(5):483-9. PubMed ID: 20958948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salvage Involved-Field and Extended-Field Radiation Therapy in Positron Emission Tomography-Positive Nodal Recurrent Prostate Cancer: Outcomes and Patterns of Failure.
    Pêtre A; Quivrin M; Briot N; Boustani J; Martin E; Bessieres I; Cochet A; Créhange G
    Adv Radiat Oncol; 2023; 8(1):101040. PubMed ID: 36483057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pancreatic Stereotactic Body Radiation Therapy With or Without Hypofractionated Elective Nodal Irradiation.
    Miller JA; Toesca DAS; Baclay JRM; Vitzthum LK; Dubrowski P; Pollom EL; Chang DT
    Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):131-142. PubMed ID: 34348171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques--a retrospective analysis.
    Kepka L; Bujko K; Zolciak-Siwinska A
    Acta Oncol; 2008; 47(1):95-103. PubMed ID: 17851862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dosimetric evaluation of the feasibility of stereotactic body radiotherapy for primary lung cancer with lobe-specific selective elective nodal irradiation.
    Komatsu T; Kunieda E; Kitahara T; Akiba T; Nagao R; Fukuzawa T
    J Radiat Res; 2016 Jan; 57(1):75-83. PubMed ID: 26566656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant Radiotherapy of Involved Field versus Elective Lymph Node in Patients with Operable Esophageal Squamous Cell Cancer: A Single Institution Prospective Randomized Controlled Study.
    Liu R; Zhang X; Zhang Q; Luo H; Wei S; Liu T; Sun S; Liu Z; Li Z; Tian J; Wang X
    J Cancer; 2021; 12(11):3180-3189. PubMed ID: 33976727
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
    Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
    Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy.
    McDonald AM; Baker CB; Popple RA; Shekar K; Yang ES; Jacob R; Cardan R; Kim RY; Fiveash JB
    Radiat Oncol; 2014 Jun; 9():129. PubMed ID: 24893842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
    Grønberg BH; Killingberg KT; Fløtten Ø; Brustugun OT; Hornslien K; Madebo T; Langer SW; Schytte T; Nyman J; Risum S; Tsakonas G; Engleson J; Halvorsen TO
    Lancet Oncol; 2021 Mar; 22(3):321-331. PubMed ID: 33662285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields.
    Bradley JD; Wahab S; Lockett MA; Perez CA; Purdy JA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):342-7. PubMed ID: 12738307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Schild SE; Fan W; Stinchcombe TE; Vokes EE; Ramalingam SS; Bradley JD; Kelly K; Pang HH; Wang X
    J Thorac Oncol; 2019 Feb; 14(2):298-303. PubMed ID: 30292852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidental irradiation of mediastinal and hilar lymph node stations during 3D-conformal radiotherapy for non-small cell lung cancer.
    Kepka L; Bujko K; Zolciak-Siwinska A; Garmol D
    Acta Oncol; 2008; 47(5):954-61. PubMed ID: 17899455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Omitting elective nodal irradiation and irradiating postinduction versus preinduction chemotherapy tumor extent for limited-stage small cell lung cancer: interim analysis of a prospective randomized noninferiority trial.
    Hu X; Bao Y; Zhang L; Guo Y; Chen YY; Li KX; Wang WH; Liu Y; He H; Chen M
    Cancer; 2012 Jan; 118(1):278-87. PubMed ID: 21598237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.
    Hoppe BS; Moskowitz CH; Filippa DA; Moskowitz CS; Kewalramani T; Zelenetz AD; Yahalom J
    J Clin Oncol; 2008 Apr; 26(11):1858-64. PubMed ID: 18332466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparative study of elective nodal irradiation and involved field irradiation in elderly patients with advanced esophageal cancer.
    Dai Y; Huang D; Zhao W; Wei J
    Front Oncol; 2023; 13():1323908. PubMed ID: 38173832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.
    Koh ES; Tran TH; Heydarian M; Sachs RK; Tsang RW; Brenner DJ; Pintilie M; Xu T; Chung J; Paul N; Hodgson DC
    Radiat Oncol; 2007 Mar; 2():13. PubMed ID: 17362522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involved-field radiation therapy for inoperable non small-cell lung cancer.
    Rosenzweig KE; Sura S; Jackson A; Yorke E
    J Clin Oncol; 2007 Dec; 25(35):5557-61. PubMed ID: 17984185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.